Periscope Capital’s Baird Medical Investment Holdings BDMD Stock Holding History

Periscope Capital’s Portfolio BDMD Stock Details BDMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-125,000	Closed	-$114K	–	449
2025 Q4	$114K	Hold	125,000	–	–	0.01%	201
2025 Q3	$245K	Hold	125,000	–	–	0.04%	147
2025 Q2	$308K	Hold	125,000	–	–	0.07%	109
2025 Q1	$431K	Hold	125,000	–	–	0.19%	77
2024 Q4	$623K	Buy	+125,000	New	+$345K	0.34%	59

Other funds holding BDMD

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Periscope Capital's BDMD Position: Q1 2026 in Review

Periscope Capital sold out of Baird Medical Investment Holdings (BDMD) in Q1 2026, closing a stake of 125,000 shares — an estimated $114K sold.

Periscope Capital first reported a position in BDMD in Q4 2024 and held it in 5 quarters. The position peaked at $623K in Q4 2024. 8 funds tracked by Wall St. Rank hold BDMD as of Q1 2026.

Periscope Capital reported no remaining Baird Medical Investment Holdings position as of Q1 2026 after selling out during the quarter.
Periscope Capital sold 125,000 Baird Medical Investment Holdings shares in Q1 2026, an estimated $114K.
Periscope Capital first reported a position in Baird Medical Investment Holdings in Q4 2024 and held it in 5 quarters.
Periscope Capital's Baird Medical Investment Holdings position peaked at $623K in Q4 2024.
8 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q1 2026.

Based on Periscope Capital's 13F filing for Q1 2026, filed 14 May 2026.